{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:43:41Z","timestamp":1790675021404,"version":"4.1.0"},"reference-count":54,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Studies suggest that hepatitis C virus (HCV) micro\u2010elimination is feasible among men who have sex with men (MSM) living with human immunodeficiency virus (HIV), through treatment\u2010as\u2010prevention and interventions aimed at reducing risk behaviours. However, their economic impact is poorly understood. The aim of this study was to assess the cost\u2010effectiveness of HCV screening and risk reduction strategies in France.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A compartmental deterministic mathematical model was developed to describe HCV disease transmission and progression among MSM living with HIV in France. We evaluated different combinations of HCV screening frequency (every 12, 6 or 3 months) and risk reduction strategies (targeting only high\u2010risk or all MSM) from 2021 onwards. The model simulated the number of HCV infections, life\u2010expectancy (LYs), quality\u2010adjusted life\u2010expectancy (QALYs), lifetime costs and incremental cost\u2010effectiveness ratio (ICER) over a lifetime horizon (leading to an end of the simulation in 2065).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All strategies increased QALYs, compared with current practices, that is yearly HCV screening, with no risk reduction. A behavioural intervention resulting in a 20% risk reduction in the high\u2010risk group, together with yearly screening, was the least expensive strategy, and, therefore, cost\u2010saving compared to current practices. The ICER per QALY gained for the strategy combining risk reduction for the high\u2010risk group with 6\u2010month HCV screening, compared to risk reduction with yearly screening, was \u20ac61,389. It also prevented 398 new HCV infections between 2021 and 2065, with a cost per infection averted of \u20ac37,790. All other strategies were dominated (more expensive and less effective than some other available alternative) or not cost\u2010effective (ICER per QALY gained &gt; \u20ac100,000).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In the French context, current HCV screening practices without risk reduction among MSM living with HIV cannot be justified on economic grounds. Risk reduction interventions targeted to high\u2010risk individuals\u2014alongside screening either once or twice a year\u2014could be cost\u2010effective depending on the policymaker's willingness\u2010to\u2010pay.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.26035","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T12:14:22Z","timestamp":1669896862000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost\u2010effectiveness of hepatitis C virus test\u2010and\u2010treat and risk reduction strategies among men who have sex with men living with HIV in France"],"prefix":"10.1002","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7406-3595","authenticated-orcid":false,"given":"Mathieu","family":"Castry","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Paris  IAME INSERM Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cousien","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris  IAME INSERM Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-4116","authenticated-orcid":false,"given":"Karen","family":"Champenois","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris  IAME INSERM Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Supervie","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Inserm Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Velter","sequence":"additional","affiliation":[{"name":"Sant\u00e9 publique France  Saint\u2010Maurice France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Ghosn","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris  IAME INSERM Paris France"},{"name":"Service de maladies Infectieuses et tropicales H\u00f4pital Bichat Claude Bernard  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris  IAME INSERM Paris France"},{"name":"Service de maladies Infectieuses et tropicales H\u00f4pital Bichat Claude Bernard  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. David","family":"Paltiel","sequence":"additional","affiliation":[{"name":"Yale School of Public Health  New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Deuffic\u2010Burban","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris  IAME INSERM Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000834"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283471cce"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029322"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv115"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2015-052052"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.012"},{"key":"e_1_2_11_8_1","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021, towards ending viral hepatitis","author":"World Health Organization","year":"2016"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.033"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13922"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.38.2001321"},{"key":"e_1_2_11_12_1","first-page":"100281","article-title":"Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015\u20132019) of data from French administrative healthcare databases (SNDS)","volume":"13","author":"Pol S","year":"2022","journal-title":"Lancet"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321744"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.10.006"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(13)60051-3"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25062"},{"issue":"3","key":"e_1_2_11_17_1","first-page":"CD001230","article-title":"Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men","author":"Johnson WD","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.2807\/ese.14.48.19430-en"},{"key":"e_1_2_11_19_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Choix m\u00e9thodologiques pour l\u2019\u00e9valuation \u00e9conomique \u00e0 la HAS.2020; Available from:https:\/\/www.has\u2010sante.fr\/upload\/docs\/application\/pdf\/2020\u201007\/guide_methodologique_evaluation_economique_has_2020_vf.pdf. Accessed on April 15 2022."},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001120"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu002"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268818000675"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25100"},{"key":"e_1_2_11_24_1","unstructured":"ANRS. \u00c9pid\u00e9miologie de l'infection VIH en France 2013\u20132018. Tendances et contribution de la pr\u00e9vention combin\u00e9e (d\u00e9pistage traitement antir\u00e9troviral des PVVIH prevention par le pr\u00e9servatif et la PrEP).2020; Available from:https:\/\/www.anrs.fr\/sites\/default\/files\/2020\u201007\/ANRS_RapportEpidemiologieVIH2013_2018_EN.pdf. Accessed on September 23 2022."},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11222-011-9288-2"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12711"},{"key":"e_1_2_11_27_1","unstructured":"Sant\u00e9 publique France. Bulletin de sant\u00e9 publique VIH\/sida. D\u00e9couvertes de s\u00e9ropositivit\u00e9 VIH et diagnostics de sida \u2010 France 2018.2019[cited 2020 May 7]; Available from:https:\/\/www.santepubliquefrance.fr\/maladies\u2010et\u2010traumatismes\/infections\u2010sexuellement\u2010transmissibles\/vih\u2010sida\/documents\/bulletin\u2010national\/bulletin\u2010de\u2010sante\u2010publique\u2010vih\u2010sida.\u2010octobre\u20102019"},{"key":"e_1_2_11_28_1","unstructured":"Indicateurs de prise en charge des PVVIH dans les COREVIH en France en 2019. Donn\u00e9es de la cohorte ANRS CO4 FHDH.2021; Available from:https:\/\/anrs\u2010co4.fhdh.fr\/psl36\/wp\u2010content\/uploads\/2022\/02\/Presentation_Rapport\u2010des\u2010indicateurs\u2010de\u2010prise\u2010en\u2010charge\u2010des\u2010PVVIH\u2010dans\u2010les\u2010COREVIH\u2010en\u2010France\u2010en\u20102019.pdf. Accessed on September 23 2022."},{"key":"e_1_2_11_29_1","unstructured":"AFEF. Recommandations AFEF pour l\u2019\u00e9limination de l'infection par le virus de l'h\u00e9patite C en France.2018; Available from:https:\/\/afef.asso.fr\/wp\u2010content\/uploads\/2018\/06\/VF\u2010INTERACTIF\u2010RECO\u2010VHC\u2010AFEF\u2010v2103.pdf. Accessed on April 15 2022."},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10371"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001467"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834dce6e"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.07.005"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215596"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30950-8"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X02238300"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1050(199709)6:5<545::AID-HEC302>3.0.CO;2-Q"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002541"},{"key":"e_1_2_11_39_1","unstructured":"Eurostat. Real GDP per capita.2019; Available from:https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/sdg_08_10\/default\/table?lang=fr. Accessed on April 30 2021."},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12919"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.027"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22375"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32830e6d51"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210179"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30031-5"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13503"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1007"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa021"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac273"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz367"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28769"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25059"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.02.006"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.01.034"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz160"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.26035","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.26035","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.26035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T11:35:14Z","timestamp":1692531314000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.26035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1002\/jia2.26035"],"URL":"https:\/\/doi.org\/10.1002\/jia2.26035","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"2022-04-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e26035"}}